Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.34 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | KDM1B | Q8NB78 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30758646 | 1.00 | AHR (0.37) | AHRCSNK2A1KDM1AKDM1B | |
| SCHEMBL3365678 | 0.83 | GPR84 (0.35) | KDM1AKDM1B | |
| SCHEMBL693457 | 0.82 | GPR84 (0.37) | KDM1AKDM1B | |
| SCHEMBL31266184 | 0.82 | GPR84 (0.37) | KDM1AKDM1B | |
| SCHEMBL11027502 | 0.80 | GPR84 (0.36) | KDM1AKDM1B | |
| SCHEMBL377065 | 0.79 | KDM1A (0.41) | KDM1AKDM1B | |
| SCHEMBL29545980 | 0.79 | KDM1A (0.41) | KDM1AKDM1B | |
| SCHEMBL377235 | 0.77 | KDM1A (0.39) | KDM1AKDM1B | |
| SCHEMBL30474348 | 0.77 | KDM1A (0.39) | KDM1AKDM1B | |
| SCHEMBL1759465 | 0.76 | AHR (0.46) | AHRCSNK2A1KDM1AKDM1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239816-A1 | BORONO-PHENYLALANINE DERIVATIVE | STELLA PHARMA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-4361159-A1 | BORONO-PHENYLALANINE DERIVATIVE | Stella Pharma Corporation (JP) | 2024-05-01 | — | — | EP | disclosed |
| CN-117545759-A | Derivatives of dihydroxyborylphenylalanine | 斯特拉制药公司 | 2024-02-09 | — | — | CN | disclosed |
| WO-2022270143-A1 | BORONO-PHENYLALANINE DERIVATIVE | ステラファーマ株式会社 | 2022-12-29 | — | — | WO | disclosed |
| US-10562912-B2 | Heterocyclic derivatives and use thereof | C&C RESEARCH LABORATORIES (KR) | 2020-02-18 | — | — | US | disclosed |
| EP-3004057-B1 | HETEROCYCLIC DERIVATIVES AND THEIR USE AS STAT 3 INHIBITORS | C&C RES LAB (KR) | 2018-07-25 | — | — | EP | disclosed |
| US-20160108056-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | C&C RESEARCH LABORATORIES (KR) | 2016-04-21 | — | — | US | disclosed |
| EP-3004057-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | C&C Research Laboratories (KR) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014196793-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | C&C RESEARCH LABORATORIES (KR) | 2014-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239816-A1 | BORONO-PHENYLALANINE DERIVATIVE | SLC7A1, SLC1A5, LATS2 | AHR 798/4885CSNK2A1 1012/4885KDM1A 2483/4885 |
| US-20160108056-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | STAT3, JAK2, STAT5A | AHR 2073/4885CSNK2A1 18/4885KDM1A 3433/4885 |
| US-10562912-B2 | Heterocyclic derivatives and use thereof | STAT3, JAK2, STAT5A | AHR 2073/4885CSNK2A1 18/4885KDM1A 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.